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MItF has a central role in regulating 
starvation-induced autophagy in 
melanoma
Katrin Möller  1, sara sigurbjornsdottir  1, Asgeir o. Arnthorsson1, Vivian pogenberg  2,  
Ramile Dilshat  1, Valerie Fock  1, solveig H. Brynjolfsdottir  1, Christian Bindesboll  3,  
Margret Bessadottir  1, Helga M. ogmundsdottir1, Anne simonsen  3, Lionel Larue  4,5,6,  
Matthias Wilmanns  2, Vesteinn thorsson  7, eirikur steingrimsson  1 & 
Margret H. ogmundsdottir  1
the MItF transcription factor is a master regulator of melanocyte development and a critical factor in 
melanomagenesis. The related transcription factors TFEB and TFE3 regulate lysosomal activity and 
autophagy processes known to be important in melanoma. Here we show that MItF binds the CLeAR-
box element in the promoters of lysosomal and autophagosomal genes in melanocytes and melanoma 
cells. the crystal structure of MItF bound to the CLeAR-box reveals how the palindromic nature of this 
motif induces symmetric MItF homodimer binding. In metastatic melanoma tumors and cell lines, MItF 
positively correlates with the expression of lysosomal and autophagosomal genes, which, interestingly, 
are different from the lysosomal and autophagosomal genes correlated with TFEB and TFE3. Depletion 
of MItF in melanoma cells and melanocytes attenuates the response to starvation-induced autophagy, 
whereas the overexpression of MItF in melanoma cells increases the number of autophagosomes but 
is not sufficient to induce autophagic flux. Our results suggest that MITF and the related factors TFEB 
and TFE3 have separate roles in regulating a starvation-induced autophagy response in melanoma. 
Understanding the normal and pathophysiological roles of MItF and related transcription factors may 
provide important clinical insights into melanoma therapy.
Autophagy is a major intracellular degradation pathway that occurs at basal levels in all cells and is necessary for 
maintaining cellular homeostasis by degrading protein aggregates, long-lived proteins, lipids and malfunctioning 
organelles. Macroautophagy (hereafter referred to as autophagy) involves the formation of a double membrane 
structure (the phagophore) that engulfs cytoplasmic material and closes to form an autophagosome, which fuses 
with the lysosome, leading to degradation of the sequestered material. Autophagy can be induced by various 
stress conditions, such as nutrient deprivation, hypoxia or infection. The autophagy process generates amino 
acids for protein synthesis and lipids for β-oxidation, thereby producing new building material and energy in 
the form of ATP for cell survival1. Autophagy plays a major role in both tumor prevention and tumor formation, 
and has been shown to promote metastasis by enhancing tumor cell fitness in response to environmental stresses 
during the metastatic process2,3.
The MiT/TFE transcription factor family, consisting of Microphthalmia-associated transcription fac-
tor (MITF), TFEB, TFE3 and TFEC, belongs to the MYC superfamily of basic helix-loop-helix leucine zipper 
(bHLH-ZIP) proteins. The basic domains are involved in binding DNA whereas the HLH and Zip domains 
are important for the dimerization. The DNA binding and dimerization domains of the MiT/TFE proteins are 
highly conserved4 and the members bind DNA as homo- and heterodimers with each other, but not with other 
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bHLH-ZIP proteins such as MYC, MAX or USF5. The MiT/TFE factors specifically bind to E- (CANNTG) and 
M-box (TCATGTGA) elements in the promoter regions of their target genes6. They are found in most vertebrate 
species7 and share a common ancestor in D. melanogaster (Mitf)8 and C. elegans (HLH-30)7. The central role of 
the sole Mitf factor in the fruit fly is to regulate the expression of all genes encoding subunits of a functional 
vacuolar H+-ATPase (v-ATPase)9–11, an ATP-dependent proton pump that is responsible for the acidification 
of the lysosome. Proper pH regulation of the lysosome is important for cellular processes such as degradation 
in lysosomes through autophagy12. Genes involved in lysosomal biogenesis and autophagy have been shown to 
be transcriptionally regulated by TFEB and TFE3 via their binding to the E-box type CLEAR (TCACGTGA) 
element13–17. Mammalian MITF on the other hand, is mainly known to regulate melanosome formation and mel-
anin production in melanocytes, a process also based on proper lysosomal pH regulation18. Additionally, MITF 
regulates genes involved in cell proliferation and survival and it plays an important role in melanoma, where it has 
been suggested to act as a lineage-specific oncogene19.
Recently, MITF has been suggested to play a role in the regulation of lysosomal biogenesis and autophagy via 
transcriptional regulation of lysosomal and autophagosomal genes20,21. Interestingly, these genes are expressed at 
higher levels in melanoma than in most other cancers and melanomas have been shown to be highly dependent 
on lysosomal and autophagic activity for both prevalence and progression22–24. Here we show that MITF binds, 
with high affinity, to promoters of a subset of lysosomal and autophagosomal genes in melanoma cells. MITF 
knockdown reduces the autophagy response to starvation in both melanocytes and melanoma cells, whereas 
MITF overexpression leads to an increased number of autophagosomes. In metastatic melanoma tumours, MITF 
mRNA levels correlate with a subset of lysosomal and autophagosomal genes, that is different to the subset of 
genes regulated by TFEB and TFE3. These results suggest a distinct role for MITF in regulating stress-induced 
autophagy in melanoma cells.
Results
MItF binds the promoters of lysosomal and autophagosomal genes. Experimental evidence has 
shown that MITF regulates expression of genes involved in diverse cellular processes in the melanocyte lineage, 
including pigment production25,26. To characterize which genes are mainly bound by MITF in melanocytes and 
melanoma cells, we analysed previously published MITF ChIP sequencing data from primary human melano-
cytes (NHEM) and from two human melanoma cell lines; COLO829 and 501mel25,27. Binding sites were assigned 
to genes using the GREAT software28. Comparison of MITF binding sites in these three data sets revealed 997 
overlapping sites, corresponding to 940 common genes in all three cell types (Fig. 1A). Gene ontology (GO) 
analysis of the MITF bound genes revealed an enrichment of lysosomal genes, in addition to melanosomal genes 
(Fig. 1B). GO analysis showed a significant presence of lysosomal and melanosomal genes among the overlapping 
genes (Fig. 1B), suggesting that these are common targets of MITF in the melanocyte lineage. Motif analysis of 
these 997 overlapping MITF binding sites in the different cell lines revealed the presence of a CLEAR-box element 
in addition to E- and M-box elements (Fig. 1C). To verify that MITF can bind to specific melanosomal and lyso-
somal genes in a human melanoma cell line, we performed ChIP on endogenous MITF in 501Mel cells, followed 
by qRT-PCR. Indeed, MITF binds to the promoters of MLANA (melanosomal gene) as well as to several lysoso-
mal and autophagosomal genes, such as LAMP1 and MAP1LC3B (LC3B), in these cells (Sup. Fig. 1A).
Figure 1. MITF binds lysosomal and autophagosomal genes in melanoma cell lines. (A) Analysis of MITF 
ChIP sequencing data from primary melanocytes27 and the two melanoma cell lines COLO82927 and 501Mel25. 
The Venn diagram shows the number of MITF binding sites in each dataset. (B) Gene ontology analysis for each 
MITF ChIP sequencing dataset. (C) Motif analysis of the shared 997 binding sites.
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MItF binds to the CLeAR-box element in a symmetric manner. We have previously shown that 
different amino acid-DNA contacts are involved when MITF binds to the M-box element than when it binds 
to the palindromic E-box element29. Using fluorescence anisotropy, we compared the binding affinity of MITF 
to the M-, E- and CLEAR-box elements, revealing similar affinity to all motifs, with a slight preference for the 
CLEAR-box (Fig. 2A, Table 1). We further measured the MITF-mediated activation of M-, E- and CLEAR-box 
elements in HEK293T cells using a luciferase trans-activation assay. Our results show that MITF activates expres-
sion from all three elements, with a slight preference for the E- and CLEAR-box over the M-box (Sup. Fig. 1B).
We solved the crystal structure of the complex formed by MITF and the CLEAR-box DNA motif (Fig. 2B). 
In contrast to what we previously observed in the MITF structures in presence of M- and E-box elements29, the 
MITF/CLEAR assembly is symmetric and associated with a crystallographic two-fold axis (Fig. 2B). In addition 
to base-specific and phosphate backbone hydrogen bonds, which are similar to the ones observed in the previous 
study29, the binding is reinforced by the van der Waals contact between I212 and hydrophobic patches at the 
surface of the DNA including the methyl moiety of the thymidine in position -4 of both half-sites of the CLEAR 
motif (Fig. 2C, Sup. Table 1). In contrast, this base is present only in one half-site of the asymmetric M-box, 
and this could explain that the affinity of MITF for the M-box is slightly lower than for the CLEAR-box. Taken 
together, these data show that MITF is fully able to recognize the CLEAR-box element and therefore activate the 
expression of lysosomal and autophagy genes through the binding of their promoters.
MITF and TFE3 negatively correlate in metastatic melanoma tumors. As autophagy levels have 
been shown to be high in melanoma, we investigated the involvement of MITF in regulating expression of lyso-
somal and autophagosomal genes in these tumors. Using RNA sequencing data from 368 metastatic melanoma 
tumors from The Cancer Genome Atlas (TCGA)30 we analysed the correlation between MITF and these genes. 
In terms of overall expression level, MITF had a 4- and 15-fold higher mRNA expression than that of TFEB and 
TFE3, respectively, in the metastatic tumors (Sup. Table 2). We included TFEB and TFE3 in our subsequent 
analyses but excluded the fourth related factor, TFEC, due to its very low expression levels in these tumors (Sup. 
Table 2). Interestingly, TFEB and TFE3 negatively correlate with MITF expression in the metastatic melanoma 
tumors (Fig. 3A). All genes were ranked according to the correlation of their expression levels with that of MITF. 
The genes bound by MITF in all three MITF ChIP sequencing data sets (Fig. 1A) have higher correlation with 
MITF in these tumors than do other genes (Sup. Fig. 2A). This indicates that the expression of genes bound by 
MITF in melanocytic and melanoma cell lines are positively regulated by MITF in melanoma tumors. Gene 
Figure 2. MITF binds the CLEAR-box motif in a symmetric manner. (A) Representative titration curves of 
each fluorescein-labeled oligonucleotide M-box (red), E-box (yellow) and CLEAR-box (orange), with MITF. 
The calculated dissociation constants are given in Table 1. (B) Crystal structure of MITF in the presence of 
16-bp oligonucleotides covering the CLEAR-box motif. Proteins are shown in cartoon representation and DNA 
is illustrated in hybrid cartoon/surface representation. Color codes: central E-box motif in yellow; bases in 
positions -4 that are different in CLEAR- and E-box are highlighted in orange. (C) Schematic presentation of 
the MITF/DNA interactions with the CLEAR-box motif. Base-specific interactions are highlighted in bold and 
remaining hydrogen bond interactions in regular characters. Hydrogen bonds are indicated with black dashed 
arrows. I212 van der Waals contacts with thymidine -4 are depicted in red.
DNA M-box E-box CLEAR-box
KD 2.6 ± 0.4 1.5 ± 0.3 0.9 ± 0.3
Table 1. Quantitative determination of MITF binding affinity for various DNA elements by fluorescence 
anisotropy, measured as KD ± standard deviations (nM).
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Set Enrichment Analysis (GSEA)31,32 performed on TCGA expression data from metastatic melanoma tumors 
revealed that the ranks of correlation of MITF with lysosomal and autophagosomal genes were higher than ranks 
expected by chance (Fig. 3B, Sup. Fig. 2B). The same was observed for the correlation of both TFEB and TFE3 
with lysosomal and autophagosomal genes (Sup. Table 3, Sup. Fig. 2B). Whereas all three factors positively asso-
ciate with lysosomal and autophagosomal genes, only MITF levels positively correlate with those of melanosomal 
genes (Sup. Table 3, Sup. Fig. 2B). In fact, TFE3 negatively correlates with the expression of melanosomal genes in 
the metastatic tumors, indicating a specific role for MITF in regulating melanosomal genes.
Next we analysed expression data from 23 melanoma cell lines33. GSEA revealed a strong positive correlation 
of MITF with both melanosomal and lysosomal genes in these cell lines (Fig. 3B, Sup. Table 3, Sup. Fig. 3A,B), 
whereas TFEB showed no correlation with these genes, and TFE3 negatively correlated with the melanosomal and 
lysosomal genes. It is important to keep in mind that MITF expression is about 50-fold higher than that of TFEB 
or TFE3 in these cells (Sup. Table 2).
In metastatic melanoma tumors, MITF, TFEB and TFE3 all show elevated correlation with lysosomal and 
autophagosomal genes (Fig. 3B, Sup. Fig. 2B). However, the expression of MITF negatively correlates with TFEB 
and TFE3 expression (Fig. 3A), raising the question whether MITF regulates a different set of lysosomal genes 
than the other factors in melanoma. Comparing the correlation of the expression of each of the transcription fac-
tors MITF, TFEB or TFE3, with the expression of genes involved in lysosomes and autophagosomes, shows that 
Figure 3. Analysis of the correlation of MITF, TFEB and TFE3 in melanoma tumors. (A) Cross comparison of 
expression levels of MITF, TFEB and TFE3 in 368 TCGA metastatic melanoma tumor samples. (B) Gene set 
enrichment analysis of expression data from 368 metastatic melanoma samples from TCGA and 23 melanoma 
cell lines33. Genes were ranked based on correlation with MITF expression and lysosomal and autophagosomal 
genes highlighted. Normalised Enrichment Score (NES), False Discovery Rate (FDR) and Nominal p values 
are shown. (C) Left: Venn diagram representing top 2,000 positively correlated genes with MITF, TFEB or 
TFE3 expression in 368 metastatic melanoma samples. Right: Venn diagram representing lysosomal and 
autophagosomal genes (135 genes), 2,000 top positively correlated genes with MITF, as well as the top 2,000 
positively correlated genes with TFE3 and/or TFEB (2,790 unique genes; 1,201 genes are positively correlated 
with both TFE3 and TFEB). (D) GO analysis on lysosomal and autophagosomal genes that uniquely correlated 
with MITF and on lysosomal and autophagosomal genes that uniquely correlated with TFEB or TFE3.
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MITF-positively correlated genes have a negative correlation with TFE3 or TFEB and vice versa (Sup. Fig. 3C). 
Analysing the 2,000 genes which separately exhibited the highest positive correlation with MITF, TFE3 or TFEB 
in the metastatic tumors, showed that whereas TFEB and TFE3 share an overlap of 1,201 correlated genes, MITF 
correlated genes do not overlap with any TFE3 correlated genes and only with 9 TFEB correlated genes (Fig. 3C). 
GO analysis on the 2,000 genes with the highest positive correlation with each factor revealed that MITF posi-
tively correlates with genes involved in mitochondrial function, membrane transport and endosomal acidification 
(Sup. Table 4). Interestingly, TFEB and TFE3 show strong correlation with genes involved in the immune response 
in these tumors, implying a distinct role for these factors in melanoma tumors.
Among the top 2,000 genes that positively correlated in expression with MITF, TFEB and TFE3, only one 
lysosomal and autophagosomal gene (GM2A) was correlated with both MITF and TFEB, whereas 37 such genes 
were uniquely correlated with MITF and 30 genes uniquely correlated with TFEB and/or TFE3 (Fig. 3C,D). We 
performed a GO analysis on these uniquely correlated lysosomal and autophagy genes and interestingly, MITF 
mainly correlated with genes involved in phagosome acidification and membrane transport (Fig. 3D). TFEB and 
TFE3 on the other hand correlated with genes involved in proteolysis and autophagosomal formation. MITF thus 
has a regulatory role within lysosomal function and autophagy in melanoma tumors, distinct from the related 
TFEB and TFE3 factors.
MItF regulates starvation-induced autophagy in melanoma cells. To determine if MITF is 
involved in autophagy regulation in melanoma cells, we performed short-term knockdown of MITF in the human 
melanoma cell line SkMel28. Treating cells with siRNA against MITF (siMITF) resulted in about 50% reduced 
MITF mRNA expression and almost a complete removal of MITF protein levels, compared to cells treated with 
control siRNA (siCTRL; Fig. 4A,D). The melanosomal gene MLANA as well as the autophagy genes p62 and 
LC3B, genes encoding for v-ATPase subunits ATP6V1G1, ATP6V1C1 and ATP6V0D2, and the lysosomal degra-
dation enzyme gene CTSD were all decreased in expression in the MITF depleted cells (Fig. 4A). To monitor if 
MITF knock-down affects autophagic flux, the degradation of long-lived proteins, labelled with 14C-Valine, was 
measured in nutrient-rich and starvation conditions in the absence or presence of Bafilomycin-A1 (Baf-A1), an 
inhibitor of autophagic degradation. We observed no difference in total autophagic degradation of long-lived 
proteins when cells were cultured in normal medium, whereas autophagic degradation was decreased upon star-
vation in siMITF treated SkMel28 cells compared to siCTRL treated cells (Fig. 4B).
The conjugation of LC3B to phosphatidylethanolamine in the autophagosomal membrane is commonly used 
as an autophagy marker, and can be analysed by fluorescent imaging as lipidated LC3 forms distinct puncta in the 
cytoplasm. Comparing LC3B antibody staining of siMITF and siCTRL treated cells revealed fewer LC3B positive 
puncta in the MITF depleted cells (Fig. 4C). Lipid-bound LC3 can also be analysed by Western blotting, as the 
lipid-bound LC3B (LC3B-II) migrates faster on an SDS gel than the non-lipidated cytosolic LC3B (LC3B-I). After 
blocking autophagic degradation with Baf-A1, both in normal and starvation medium, we observed a reduction 
in LC3B-II levels in MITF depleted cells (Fig. 4D,E), indicating fewer autophagosomes. SQSTM1 (p62) levels 
were significantly lower after MITF depletion, and even though this would normally suggest increased autophagic 
degradation, p62 is a direct MITF target25 (Fig. 4A), complicating its use as a readout of autophagic activity. 
Nevertheless, p62 protein levels were increased after Baf-A1 treatment, but to a much lower extent than in control 
cells. Taken together, our results indicate that in SkMel28 melanoma cells, MITF knockdown decreases autopha-
gosome formation, followed by a reduction in global autophagic degradation.
To determine if this effect on autophagosomal formation is specific to melanoma cells, we investigated whether 
knocking down MITF also affects autophagy in human primary normal epidermal melanocytes (NHEM). 
Analysis of melanosomal and lysosomal gene expression by qRT-PCR showed reduced expression of MLANA 
and the lysosomal and autophagosomal genes ATG4B, p62, ATP6V1G1 and ATP6V1C1, as well as proteolytic 
genes GNS and CTSD, upon MITF knockdown (Sup. Fig. 5A). No difference was detected in the degradation of 
long-lived proteins when the cells were cultured in normal medium. However, autophagic flux was decreased 
upon starvation of the NHEM cells treated with siMITF compared with a control siRNA (Sup. Fig. 5B). Using 
Western blot analysis of LC3B lipidation, we observed a decrease in LC3B-II upon MITF knockdown when grown 
in normal medium (Sup. Fig. 5C,D), indicating that fewer autophagosomes are being formed. Consistent with 
the results in SkMel28 cells, p62 levels were significantly lower in the MITF depleted NHEM cells, both in normal 
and starvation medium. Taken together, these data suggest that MITF knockdown results in decreased global 
starvation-induced autophagic degradation in both NHEM melanocytes and SkMel28 melanoma cells.
To investigate whether increased MITF expression alters autophagy activity in melanoma cells, we used 
Lu1205 cells, a melanoma cell line with very low endogenous MITF expression33, to generate a stable cell line car-
rying a construct which allows doxycycline-induced activation of MITF-M using the reverse tetracycline-system 
(Fig. 5A). After 48 hours of doxycycline induction, expression levels of the lysosomal and autophagosomal genes 
LC3B, ATP6V1G1, ATP6V0D2 and CTSD were increased (Fig. 5B). However, MITF overexpression did not affect 
autophagic flux, measured by the degradation of long-lived proteins (Fig. 5C). Nevertheless, comparing LC3B 
antibody staining of MITF overexpressing cells and control cells revealed an increase in the number of LC3B 
positive puncta in MITF expressing cells (Fig. 5D). Consistently, LC3B-II levels, measured by Western blotting, 
were higher after MITF overexpression, in both normal and starvation conditions (Fig. 5E,F), which suggests an 
increase in the number of autophagosomes. There was a small, non-significant increase in p62 levels upon MITF 
overexpression, presumably reflecting MITF mediated transcriptional regulation of p62 (Fig. 5E,F).
In summary, our results show that MITF knockdown decreases the expression of several lysosomal and 
autophagosomal genes and reduces the autophagic response to starvation in both melanoma cells and primary 
melanocytes. However, while overexpression of MITF in the MITF-low melanoma cells increases expression of 
several lysosomal and autophagosomal genes and results in increased autophagosome formation, MITF is not 
sufficient to drive a global increase in autophagy-mediated protein degradation.
www.nature.com/scientificreports/
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Discussion
MITF is highly expressed in melanocytes and is required for melanocyte development and function, including 
formation of melanosomes and melanin production. Here we show that MITF also plays a central role in regulat-
ing the autophagy response to starvation in melanoma cells. We show that MITF binds the CLEAR box element 
in the promoters of lysosomal and autophagy genes, previously characterized as a preferred motif for TFEB and 
TFE316. The crystal structure of MITF bound to the CLEAR-box element revealed symmetric binding of the 
Figure 4. MITF regulates starvation-induced autophagy in SkMel28 melanoma cells. (A) Relative quantitative 
reverse transcription PCR (qRT-PCR) analysis of selected targets in SkMel28 cells treated with siMITF 
compared with siCTRL (siCTRL is normalised to 1 for all targets and not shown). An average of 3 independent 
experiments is shown. Error bars represent SEM, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (B) 
Degradation of long-lived proteins measured by 14C labelled Valine in SkMel28 cells treated with siMITF 
compared with control siRNA, incubated with or without Baf-A1 while grown in either normal culture medium 
or starved in HBSS for 4 hours. Each bar represents the difference of degradation in untreated and Baf-A1 
treated cells, thus representing degradation by autophagy. An average of three independent experiments is 
shown. Error bars represent SEM, **P < 0.01. (C) Immunostaining of SkMel28 cells treated with siMITF or 
siCTRL, showing MITF (red), LC3B (green), and DAPI (blue) staining. Scale bar is 20 µm. Boxplot represents 
number of LC3B puncta per cell. **P < 0.01. (D) Immunoblot of protein lysate from siMITF and siCTRL 
treated SkMel28 cells cultured in normal medium or starved in HBSS for 4 hours with or without 100 nM 
Baf-A1. The blots were stained with C5 anti-MITF, anti-Actin, anti-p62 and anti-LC3B antibodies. The figure 
is representative of three independent experiments. Full scan of blots are found in Supplementary Fig. 4. (E) 
Quantification of the intensity of LC3B-II and p62 bands from immunoblot in C, normalised to Actin band 
intensity. An average of three independent experiments is shown. Error bars represent SEM, **P < 0.01.
www.nature.com/scientificreports/
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Figure 5. MITF overexpression increases the number of autophagosomes in Lu1205 melanoma cells. (A) 
An inducible stable Lu1205 melanoma cell line was generated, carrying a construct which allows doxycycline 
induced expression of MITF-M-Flag using the reverse tetracycline-system (Lu MITF). A comparable cell line 
carrying an empty vector (Lu EV) was used as a control. (B) qRT-PCR analysis of selected targets in the Lu1205 
overexpression cells after 48 hours of induction, compared to the EV control cell line (EV is normalised to 1 
for all targets and not shown). An average of 3 independent experiments is shown. Error bars represent SEM, 
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (C) Degradation of long-lived proteins measured by 
14C labelled Valine in MITF overexpressing Lu1205 cells (Lu MITF) and control cells (Lu EV), treated with 
or without Baf-A1 while grown in either normal culture medium or starved in HBSS for 4 hours. Each bar 
represents the difference of degradation in untreated and Baf-A1 treated cells, thus representing degradation 
by autophagy. An average of three independent experiments is shown. Error bars represent SEM. (D) 
Immunostaining of MITF overexpressing Lu1205 cells (Lu MITF) and control cells (Lu EV) showing Flag (red) 
and LC3B (green) staining. Scale bar is 20 µm. Boxplot represents number of LC3B puncta per cell. Only MITF 
positive cells were analysed in the MITF-induced cells. ****P < 0.0001. (E) Immunoblot of protein lysate from 
MITF overexpressing cells (Lu MITF) and control cells (Lu EV) cultured in normal medium or starved in HBSS 
for 4 hours with or without 100 nM Baf-A1. The blots were stained with anti-Flag, anti-Actin, anti-p62 and anti-
LC3B antibodies. The figure is representative of six independent experiments. Full scan of blots are found in 
Sup. Fig. 4. (F) Quantification of the intensity of LC3B-II and p62 bands from immunoblot in D, normalised to 
Actin band intensity. An average of 6 independent experiments is shown. Error bars represent SEM, *P < 0.05, 
**P < 0.01.
www.nature.com/scientificreports/
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homodimer to DNA. In our previous study29, we showed that MITF is capable of binding efficiently to both M- 
and E-boxes, in contrast to other bHLHZip transcription factors such as MAX and MYC which recognize mainly 
the E-box type of motif34. Here we show that this ability relates to the van der Waals contacts between I212 and 
T-4 allowing optimal binding to the CLEAR-box. Indeed, MITF, TFE3 and TFEB have a perfectly conserved basic 
region29 and can all bind the CLEAR box.
Analysis of expression data from metastatic melanoma tumors suggests that MITF has a role that is distinct 
from the role of TFEB and TFE3 in these tumors. MITF expression correlates with the expression of melanosomal 
genes in metastatic melanoma samples as well as in a panel of human melanoma cell lines. This is in concordance 
with the previously described role of MITF. MITF expression also correlates with the expression of lysosomal and 
autophagosomal genes in metastatic melanoma samples, as do TFEB and TFE3. However, the expression of TFE3 
and TFEB negatively correlates with MITF expression in melanoma tumor samples. Interestingly, MITF correlates 
with genes required for endosomal trafficking and endosomal transporters, consistent with previous findings 
showing the involvement of MITF in the regulation of the v-ATPase9, whereas, TFEB and TFE3 mainly correlate 
with degradation enzymes involved in proteolysis. Due to their common origin, these factors still share a group of 
target genes. However, after their divergence, the individual family members, MITF, TFEB and TFE3, each have 
acquired more specific roles by adding or losing target genes.
TFEB and TFE3 have been shown to regulate lysosomal and autophagosomal gene expression in response 
to several stress factors including starvation35. We have shown that MITF is involved in regulating this response 
in melanocytes and melanoma cells. We observed that MITF knockdown leads to reduced starvation-induced 
autophagy degradation in both melanocytes and melanoma cells, presumably because of less autophagosomal 
formation. Consistent with that, the expression of lysosomal and autophagosomal genes was decreased upon 
MITF knockdown. While overexpressing MITF increased the expression of lysosomal and autophagosomal genes 
and induced autophagosome formation, MITF induction did not result in increased autophagy degradation, 
indicating that alone, MITF is not sufficient to fully drive autophagic degradation. This is in agreement with a pre-
vious publication showing that MITF induction increases the formation of lysosomes that are not fully active20. It 
remains to be clarified whether all MiT/TFE factors need to be expressed for a full response.
When nutrients are abundant, TFEB, TFE3 and a long isoform of MITF (MITF-A) are detained in the cyto-
plasm through mechanistic target of rapamycin kinase (mTOR) mediated phosphorylation; mTOR complex1 
(mTORC1) interacts with the N-terminus of these proteins in order to mediate phosphorylation17,36–38. During 
cellular stress or starvation, mTORC1 becomes inactive and the MITF/TFEB/TFE3 proteins are dephosphoryl-
ated resulting in their translocation to the nucleus14,17,37. In melanocytes and melanoma cells, the dominant iso-
form is MITF-M39 that lacks the N-terminal interaction site with mTORC1 and is therefore mostly nuclear under 
all conditions38. The role and importance of localisation and heterodimerization of MITF, TFEB and TFE3 in 
melanoma cells remains to be explored and may reveal why MITF regulates a distinct set of genes compared to 
the other factors.
In metastatic melanomas TFEB and TFE3 positively correlate with the expression of genes required for the 
immune response. These factors have previously been suggested to have a role in the immune system16,35,40,41. This 
role of TFEB and TFE3 in immune response in melanoma needs to be explored further, as this raises important 
therapeutic questions about their role in immunotherapy, a key treatment option for melanoma.
It is becoming clear that misregulation of vesicular trafficking is one of the hallmarks of melanomas and that 
melanomas are dependent on lysosomal activity and autophagy23,42. Autophagy has even been linked to increased 
invasiveness in melanoma and is believed to be a key modulator of inflammation and immune responses in these 
cancers18. Our results further link the MiT/TFE factors to these processes and underline the need to understand 
better how to target this pathway in melanoma and other cancers.
Materials and Methods
Cell culture. Three human melanoma cell lines were used in this study, 501Mel cells (a gift from Ruth 
Halaban)43, SkMel28 cells (#HTB-72, ATCC) and Lu1205 (a gift from Meenhard Herlyn, Wistar Institute, 
Philadelphia). These cells were all grown in RPMI 1640 medium (#52400-025, GIBCO) supplemented with 10% 
fetal bovine serum (FBS #10270-106, GIBCO). The primary normal human epidermal melanocytes (NHEM) 
were purchased from PromoCell (#C-12402) and were grown in Melanocyte growth medium M2 (#C-24300, 
PromoCell). Cells were grown at 37 °C and 5% CO2 and medium was changed three times per week.
Generation of inducible MItF overexpression cell lines. The Lu1205 cells were transfected with 
three piggybac vectors, containing a reverse-tetracyclin transcription activator (rtTA), a transposase and mouse 
MITF-M-FLAG-HA construct or an empty piggybac vector (EV). The piggybac vectors were a kind gift from 
Dr. Kazuhiro Murakami (Hokkaido University)44. Selection was performed with 0.5 mg/ml G418 (#10131-035, 
GIBCO) for 8 days to obtain stable cell lines and 1 μg/mL doxycycline was used for induction.
RNAi treatment. Cells were cultured in a 6 well plate for 24 hours before transfection with appropriate 
siRNA. Cells were transfected with 25 μM siRNA and 1 μL transfection reagent DharmaFECT (#T-2001-02, 
Dharmacon) per mL of culture medium. Cells were cultured for 2 days before extracting RNA or protein. The 
siRNAs used for the procedure were an siRNA for human MITF (#4390824, ID s8792, Ambion) and a control 
siRNA (sequence: 5′-UUCUCCGAACGUGUCACGUdTdT-3′, Dharmacon) that has been previously used45.
protein extraction and immunoblotting. For protein extraction, cells were cultured in 6, 12 or 24 well 
plates and lysed with Laemmli buffer and boiled at 95 °C for 5 minutes. The samples were then run on 8% or 12.5% 
SDS gels and blotted onto a 0.2 μm PVDF membrane (#88520, Thermo Scientific). The membranes were blocked 
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with 3% BSA in TBS-T (0.1% Tween 20 in TBS) for 1 hour at room temperature, and stained over-night at 4 °C 
with 5% BSA in TBS-T and appropriate primary antibodies. The following primary antibodies were used: MITF 
(MS771-PABX, Thermo Scientific), Flag-M2 (F3165, Sigma), LC3B (#2775, CST), p62 (#88588, CST) and Actin 
(MAB1501, Millipore and #4970, CST). Membranes were washed with TBS-T and stained for 1 hour at room 
temperature with appropriate secondary antibodies. The secondary antibodies used were: anti-mouse IgG(H + L) 
DyLight 800 conjugate (#5257, CST) and anti-rabbit IgG(H + L) DyLight 680 conjugate (#5366, CST). The images 
were captured using Odyssey CLx Imager (LI-COR Biosciences).
Gene expression analysis using relative quantitative real-time pCR. Total RNA was extracted from 
cells using TRIzol reagent (#15596-026, Ambion), DNase treated using the RNase free DNase kit (#79254, Qiagen) 
and re-purified with the RNeasy Mini kit (#74204, Qiagen). The cDNA was generated with High-Capacity cDNA 
Reverse Transcription Kit (#4368814, Applied Biosystems). All procedures were performed according to manu-
facturer’s instructions. Primers were designed for each target gene using NCBI Primer BLAST (Sup. Table 5), and 
qRT-PCR was performed with SYBR-Green mix (#4438, Sigma-Aldrich) using an Applied Biosystems 7500 qPCR 
machine (annealing at 60 °C). The qRT-PCR reactions were performed using 5 ng cDNA per 20 µl reaction, in 
triplicates and relative gene expression was calculated with the D-ΔΔCt method46, using the geometric mean of 
β-Actin and human ribosomal protein lateral stalk subunit P0 (RPLP0) expression to normalise gene expression 
of target genes. Standard curves were made for each primer pair and the efficiency calculated using the formula 
E = 10[−1/slope].
Immunostaining. Cells were seeded onto 8-well chamber slides (#354108 from Falcon) and cultured for 
2 days. At day 2, cells were fixed for 20 minutes with 4% paraformaldehyde (PFA) in PBS. Cells were washed 3 
times with PBS and blocked with blocking buffer (5% Normal goat serum and 0.3% Triton-X in PBS) for 1 hour 
at room temperature and stained over-night at 4 °C with the appropriate primary antibodies diluted in antibody 
buffer (1% BSA and 0.3% Triton-X in PBS). Primary antibodies were: MITF (MS771-PABX, Thermo Scientific), 
Flag-M2 (F3165, Sigma) and LC3B (#2775, CST). Cells were washed 3 times with PBS and stained for 1 hour 
at room temperature with the appropriate fluorescently labelled secondary antibodies (Thermo Scientific), 
diluted in antibody buffer. The wells were washed once with PBS, followed by DAPI staining (#D-1306, Life 
Technologies) and two additional washes with PBS only. Subsequently, slides were mounted in Fluoroshield 
(#F6182, Sigma-Aldrich) and images were acquired using an Olympus FC1200 confocal microscope. LC3B posi-
tive puncta were counted using the CellProfiler software and the number of puncta was normalised to the number 
of nuclei. For MITF-induced Lu1205 cells, LC3B positive puncta were only counted in MITF-FLAG positive cells.
Luciferase transcriptional activation assay. HEK293T cells were seeded in a 96 well and transfected 
the following day with MITF-M (#38131, Addgene) and a pGL3-basic luciferase construct containing a modified 
Tyrosinase promoter with two M-(TCATGTGA), E-(CCACGTGC) or CLEAR-(TCACGTGA) box elements, or 
scrambled elements (ACCTTCAG/GTCTAGAT), along with an internal control construct, Renilla. A total of 
110 ng of DNA were transfected per well, 33 ng per construct. 24 hours after transfection the cells were lysed using 
the Dual-Glo® Luciferase Assay System (#E2940, Promega) and the luminescence measured in a Modulus™II 
microplate multimode reader (Turner Biosystems). Data was analysed by normalising luciferase luminescence to 
Renilla luminescence (Luciferase/Renilla) and normalising luminescence of each transcription factor to empty 
vector by subtraction.
Long-lived protein degradation assay. Cells were grown in 24 well plates for 48 hours in normal 
medium supplemented with 10 mM 14C-L-Valine. At day 2 cells were washed with warm PBS and grown in RPMI 
and 10% FBS supplemented with 10 mM L-Valine for 16 hours. At day 3 the medium was changed to (a) RPMI, 
10 mM Valine and vehicle control (DMSO), (b) RPMI, 10 mM Valine and 100 nM Baf-A1, (c) HBSS (#14025-050, 
Gibco), 10 mM Valine and vehicle control (DMSO) or (d) HBSS, 10 mM Valine and 100 nM Baf-A1. After 4 hours, 
the supernatant was collected, 50% TCA added and proteins precipitated over-night at 4 °C. The cells were lysed 
with 0.2 M KOH over-night at 4 °C. The supernatant was centrifuged and moved to a new tube, the precipitate 
dissolved and moved to the same sample cell lysate. Both supernatant and lysate were moved to counting vials and 
mixed with 3 mL scintillation fluid (Ultima Gold #6013321, Perkin Elmer). 14C levels were measured in each sam-
ple using a Packard Liquid Scintillation Analyser. The % degradation was calculated by comparing the amount 
of 14C in the supernatant to the total 14C levels (supernatant and lysate). The autophagic flux was calculated by 
subtracting the % degradation of the Baf-A1 treated sample from the untreated sample, for each culture medium.
Gene expression analysis from melanoma cell lines. The GSEA analysis was performed using the 
GSEA software from the Broad Institute31,32. The list of lysosomal and autophagosomal genes used has been 
described previously21 and the list of melanosomal genes was generated from melanosomal GO gene sets 
(GO:0042470, GO:0032438 and GO:0032400). These lists of 135 melanosomal genes and 132 lysosomal genes 
have an overlap of 11 genes.
Chromatin Immunoprecipitation ChIp-qpCR. Chromatin immunoprecipitation was performed 
as described (Shaffer et al., 2008) with the following modifications: Thirty million cells were crosslinked with 
0.4% formaldehyde, and chromatin was sheared by sonication using a probe sonicator (Epishear, Active Motif). 
Immunoprecipitation was performed with Protein G Dynabeads (10003D, Life technologies), with a total of 10 µg 
of anti-MITF antibody (Cosmo Bio Co., BAM-73-107-EX)47. Purified ChIP samples and corresponding input 
DNA were analysed by qRT-PCR using SYBR-Green mix (#4438, Sigma-Aldrich) on an ABI 7500 qPCR machine 
(annealing at 60 °C) using region specific primers (Sup. Table 6). The resulting qPCR data were then analysed as 
described above.
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ChIp-seq data analysis. MITF-ChIP-seq data with accession number GSE50681: SRX346923 (COLO829) 
and SRX346921 (Melanocyte) were downloaded from the SRA archive; 501Mel with accession number 
GSE61965. Raw reads were aligned to hg19 with bowtie1 with command -v 2 -m 1–best and peaks were called 
with MACS14. The Bioconductor package DiffBind was used to find overlapping peaks in different cell types, 
COLO829, 501Mel, and Melanocyte. Overlapping peak sets were annotated and GO analysis performed using 
GREAT28.
Genome-wide gene expression data. 23 melanoma cell lines were analysed with respect to gene expres-
sion (Agilent gene expression data as previously described)33. All available TCGA melanoma (SKCM) data were 
retrieved from the TCGA Data Coordinating Center on June 14, 2015 and processed through the TCGA pipeline 
at the TCGA Genome Data Analysis Center at the Institute for Systems Biology. After exclusion of Redacted cases, 
109 primary tumor samples and 368 metastatic tumor samples remained, corresponding to 470 participants. We 
included the 368 metastatic tumor samples in our analysis. Gene expression matrices were generated for all sam-
ples with available (TCGA Level 3) gene expression values (from RNA-Seq, as RSEM values), resulting in a matrix 
for metastatic tumor samples (368 samples; 20,531 genes). Venn diagrams were plotted using jvenn software48. 
GO analysis was performed using the DAVID Bioinformatics Resources 6.849,50.
MItF purification and crystallization and X-ray structure determination. The following oli-
gonucleotide was synthesized at METABION (Planegg/Steinkirchen, Germany) and annealed through 
incubation at 95 °C for 5 minutes, followed by a passive cooling step to room temperature: CLEAR-box: 
5′- AGTATCACGTGATACT-3′.
The MITF/DNA complex was purified as previously reported29. Crystals grew from 0.9 M sodium malonate 
(pH 5.5). Crystals were soaked in cryo-solutions containing the crystallization mother liquor supplemented with 
25% [v/v] glycerol, mounted onto a cryoloop (Hampton Research), and flash-cooled in liquid nitrogen. X-ray 
data were collected on the MASSIF-1 beamline at ESRF, Grenoble, France. Diffraction data were processed using 
XDS and scaled with AIMLESS from the CCP4 suite51. The structure was solved by molecular replacement using 
the program PHASER52 and refined with the PHENIX suite53 and REFMAC554. The final model was built with 
COOT55. The stereochemical quality of the structures was assessed with MolProbity56. X-ray structure determi-
nation and refinement statistics are listed in Sup. Table S1. The atomic coordinates and structure factors have been 
deposited at the Protein Data Bank under the identification code 6G1L.
Fluorescence anisotropy assay. The following fluorescein-labeled oligonucleotides were synthesized at 
METABION (Planegg/Steinkirchen, Germany) and annealed with complementary unlabeled oligonucleotides as 
described in the previous section:
CLEAR-box: 5′-GAGATCACGTGATGAC-3′-Fluorescein
E-box: 5′-GAGACCACGTGTTGAC-3′-Fluorescein
M-box: 5′-GAGATCATGTGTTGA C-3′-Fluorescein
Increasing concentrations of MITF proteins were incubated with the respective dsDNA oligonucleotides 
at a final concentration of 0.5 nM at 25 °C for 5 minutes in 10 mM Tris/HCl pH 7.5, 300 mM NaCl, 0.01% 
TRITON-X100, and 0.1 mg/mL BSA. Fluorescence anisotropy was then measured using an Infinite M1000 plate 
reader (TECAN) using the excitation diode at 470 nm and detecting the emitted light at 530 nm. Binding data 
were analysed using the GraphPad Prism software. Binding profiles were fitted using a simple model assuming a 
stoichiometry of one MITF dimer per double stranded DNA fragment. KD values reported in Table 1 correspond 
to the means of three independent measurements and the +/− error numbers represent the standard deviations.
statistical analysis. Results from three or more independent experiments are presented as the mean with 
standard error of the mean (SEM). Graphpad Prism 7 was used for statistical analysis. Statistics for LC3B-positive 
puncta from confocal images were calculated using a two-tailed, unpaired t-test. LC3B positive puncta were 
counted using the CellProfiler software (80–350 cells analysed per cell line). Statistics of the long-lived protein 
degradation (LLPD) assay, immunoblotting and immunostaining experiments and qRT-PCR analysis for knock-
down and overexpression experiments, were calculated using multiple t-tests and a false discovery rate of 5%. 
Significant differences of the mean are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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